INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cumberland Pharmaceuticals Inc. - CPIXGlobeNewsWire • Tuesday
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cumberland Pharmaceuticals Inc. - CPIXPRNewsWire • 11/12/26
Cumberland Pharmaceuticals Inc. (CPIX) Q3 2026 Earnings Call Prepared Remarks TranscriptSeeking Alpha • 11/10/26
CPIX Investors Have Opportunity to Join Cumberland Pharmaceuticals Inc. Fraud Investigation with SBS LawBusiness Wire • 11/05/26
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTSPRNewsWire • 11/03/26
Cumberland Pharmaceuticals Inc. (CPIX) Discusses Duchenne Cardiomyopathy NDA Submission and Product Development Strategy Prepared Remarks TranscriptSeeking Alpha • 10/26/26
Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne CardiomyopathyMarketBeat • 10/26/26
CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAMPRNewsWire • 10/26/26
CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALLPRNewsWire • 10/23/26
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAMPRNewsWire • 10/19/26
Cumberland Pharmaceuticals: Pivot Into Drug Development Creates Risk, OpportunitySeeking Alpha • 08/13/26
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTSPRNewsWire • 07/28/26
Apotex Completes Previously Announced Strategic Transaction with Cumberland PharmaceuticalsPRNewsWire • 07/01/26
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual ConferencePRNewsWire • 06/26/26